Post-Genomic Cardiology

Post-Genomic Cardiology

List price: US$210.00

Currently unavailable

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

Recent advances in molecular and cellular biology have markedly changed our understanding of the heart, and this is having tremendous ramifications for the clinician. This unique reference offers a comprehensive and critical evaluation of this contribution in the field of cardiovascular molecular medicine providing the reader with a sense of new directions in which molecular medicine might be applied. It begins with a detailed primer that makes readily accessible recent molecular, genetic and cellular techniques. Rounding out the coverage of this exciting field are critical and comprenhesive discussions on the use of molecular, genetic and cellular techniques used to identify the etiology and pathophysiology of specific cardiac diseases.
show more

Product details

  • Hardback | 688 pages
  • 215.9 x 281.9 x 30.5mm | 1,769.03g
  • Academic Press Inc
  • San Diego, United States
  • English
  • New ed.
  • 0123736986
  • 9780123736987

Table of contents

BIOCHEMICAL, CELLULAR AND MOLECULAR FUNCTIONING OF THE HEART
Introduction to Post-Genomic Cardiology
Molecular and Biochemical Methodology in the Post-Genomic Era
Cardiovascular Gene Expression
Cellular Techniques
Cardiovascular Signaling Pathways
PEDIATRIC CARDIOLOGY IN THE POST-GENOMIC ERA
Cardiac Development: Molecular and Genetic Analysis
Congenital and Adquired Heart Disease
POST-GENOMIC ANALYSIS OF CORONARY ARTERY DISEASE, ANGIOGENESIS AND HYPERTENSION
Molecular Basis of Lipoproteins Disorders, Atherogenesis and Thrombosis
Ischemia and Myocardial Infarction: A Post-Genomic Appraisal
Cellular Pathways and Molecular Events in Cardioprotection
Cardiac Neovascularization: Angiogenesis, Arteriogenesis and Vasculogenesis
Systemic and Pulmonary Hypertension
POSTGENOMIC ANALYSIS OF THE MYOCARDIUM
Cardiomyopathies
Heart Response to Inflammation and Infection
THE FAILING HEART
Molecular analysis of heart failure and remodeling
MOLECULAR AND GENETIC ANALYSIS OF METABOLIC DISORDERS
Fatty Acid and Glucose Metabolism in Cardiac Disease
MOLECULAR GENETIC OF DYSRHYTHMIAS
Dysrhythmias and Sudden Death
GENES, GENDER AND ENVIRONMENT
Gender and Cardiovascular Disease
AGING AND THE CARDIOVASCULAR SYSTEM
The Aging Heart: A Post-Genomic Appraisal
LOOKING TO THE FUTURE
Future of Post-Genomic Cardiology
GLOSSARY
INDEX
show more

Review quote

Post-Genomic Cardiology. Second Edition

By Jose Marin-Garcia.

Academic Press; 2014: 924 pages, 84 tables and 194 figures. ISBN: 978-0-12-404599-6

Seven years ago, I was given the opportunity to review the first edition of this book, which was published in 2007. Dr. Jose Marin-Garcia has updated and revised a new edition of that work. In these 7 years, we have been witnesses to the great surge in research into the genetic and molecular bases of cardiovascular disease. The use of omics has contributed enormously to this advance in the existing knowledge. The study of the genetic bases of diseases, building on linkage studies, genome-wide association studies, and genome sequencing (genomics), together with the new methods for studying gene expression (transcriptomics) and its regulation (epigenomics), advances in the quantification of proteins (proteo- mics) and their metabolites (metabolomics), the study of the molecular mechanisms that take place within the cell, such as signaling pathways and cascades, cell reprogramming, and the integration of all this information through the systems biology and the bioinformatics, have contributed to these advances. In this book, the author presents an ambitious review of all these aspects, focusing not only on genomic aspects, but on post-genomic aspects and their contribution to the current knowledge of the molecular bases of heart disease as well.

As I mentioned in my review of the earlier edition, the fact that the book was written by a single author, with the participation of three close associates, lends consistency and uniformity to the different chapters and facilitates their reading. Each chapter finishes with a highly useful summary that presents the main conclusions and the most important messages. The majority of the chapters provides a very extensive list of references (updated as of 2012), which facilitates the consultation of the original sources of the information. There are many tables summarizing the data and, in this new edition, the quality of the figures and graphs has improved quite notably.

The current edition has 11 well differentiated sections, each of which is divided into several chapters (between 1 and 5) that deal with different aspects related to the genomics of heart disease. With respect to the earlier edition, the contents have been updated and include new sections or chapters that are mainly related to the relevance of epigenetics and the mitochondrion to heart disease.

Section I offers a general introduction to the biochemical, cellular, and molecular functions of the heart under normal conditions. This section includes 3 chapters, the first 2 of which have been extensively rewritten. The 3 chapters introduce and review basic concepts related to gene structure, the processes of transcription and protein synthesis, and the cell cycle. The second chapter presents the methods for studying cardiac function at the molecular level, focusing on the different omics . The last chapter of the section provides a review of the cell signaling pathways that regulate the growth, proliferation, and function of different cardiac cell lines. The author has updated the review of cell receptors and mitochondrial signaling, but the review of the intracellular pathways (adenyl cyclase, phospholipase, mitogen-activated protein [MAP] kinase, protein kinase, etc.), calcium signaling, and signals for cell cycle regulation, proliferation, and apoptosis has not been updated to any great extent in this second edition.

In section II, which is completely new, the author presents an excellent review, in 2 chapters, of the molecular mechanisms involved in embryonic heart development. In the first, he reviews the different signaling pathways and certain epigenetic factors that influence and regulate cell reprogramming in normal heart development; the second describes the known molecular changes that explain different congenital heart diseases.

Section III is the most extensive, with 5 chapters devoted to the analysis of arteriosclerosis, ischemic heart disease, angiogenesis, and hypertension. The first chapter describes the molecular mechanisms of arteriosclerosis and the second, the genetic bases of ischemic heart disease. In this second chapter, considerable weight is still given to evidence (often debatable) from linkage studies in family groups and from studies based on candidate genes. ..

Sections IV and V have also been extensively updated and restructured, and focus on the study of myocarditis, cardiomyopa- thies, and heart failure. They describe the genes and signaling pathways involved in cardiomyopathies (hypertrophic, idiopathic dilated, and restrictive cardiomyopathy and arrhythmogenic right ventricular dysplasia), in the cardiac response to inflammation and infection, and in the development of heart failure in patients with ischemic heart disease or hypertension. In this respect, the author has updated the content concerning ventricular remodeling, apoptosis and oxidative stress, and mitochondrial function in heart failure.

The book also reviews the molecular bases of arrhythmias, describing the genes involved in different channelopathies and in atrial fibrillation. The author presents and describes certain mutations than can be associated with a poorer prognosis in several heart diseases, although he admits that there are still many gaps in the current knowledge and, thus, cannot support their systematic utilization, and considers it necessary to continue to investigate the molecular mechanisms that regulate the different clinical presentations of a given genetic mutation.

Section VIII has only 1 chapter, which analyzes aspects related to sex differences in the context of cardiovascular diseases.

The last 3 sections are very new and provide an exhaustive presentation of aspects related to the aging of the heart and cardiovascular system (3 chapters), the epigenetic mechanisms related to cardiovascular diseases, and possible new therapeutic horizons that all this knowledge is opening along the path toward personalized cardiovascular medicine.

In conclusion, as I commented with regard to the previous edition, this is a highly interesting book that focuses on molecular mechanisms related to different heart diseases, which undoubtedly can be of great utility to cardiologists and researchers in different areas (pharmacology, basic research, clinical practice, epidemiology) who are interested in these mechanisms.

Roberto Elosua

Epidemiolog a y Genetica Cardiovascular.

Instituto Hospital del Mar de Investigaciones Medicas, Barcelona, Spain

E-mail address: relosua@imim.es"
show more

About José Marín-García

Dr.Jos Mar n-Garc a is the current Director of Molecular Cardiology and Neuromuscular Institute in Highland Park, NJ. He has 127 listed publications and an H-index of 18. He has written and edited Mitochondria and the heart (2005), Aging and the Heart (2008), Signaling in the Heart (2008). Heart Failure (2010), Post-Genomic Cardiology (2007), and Mitochondria and Their Role in Cardiovascular Disease (2012).
show more